跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12 条关于
“Vorangio”
全部
12
临床试验
4
药物
0
机构
0
资讯
8
10个月前
Real-World Study Reveals Treatment Gap in IDH-Mutant Glioma, Supporting Need for Early Intervention
2年前
FDA Approves Vorasidenib (Voranigo) for IDH-Mutant Grade 2 Glioma
去年
FDA Approves Voranigo: First Targeted Therapy for IDH-Mutant Glioma Brain Cancer
去年
FDA Approves Voranigo (Vorasidenib) as First Targeted Therapy for IDH-Mutant Glioma
4个月前
Servier to Present Long-Term VORANIGO Data and Novel ADC Results at ASCO 2026
2年前
FDA Approves Vorasidenib (Voranigo) for IDH-Mutant Glioma, Developed from Duke Neurosurgeon's Discovery
去年
Health Canada Approves Vorasidenib (Voranigo) as First Targeted Therapy for IDH-Mutant Glioma
6个月前
CathWorks FFRangio Demonstrates Non-Inferiority to Invasive Pressure Wire Assessment in Landmark ALL-RISE Trial